Search research articles

Search research articles

Related Experiment Videos

Endotoxin, cellular immune dysfunction and acute pancreatitis

¹Royal College of Surgeons of England, London.

Annals of the Royal College of Surgeons of England

|November 1, 1996

Summary

This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Vascular surgery is an unattractive career option for current basic surgical trainees: a regional perspective.

Annals of the Royal College of Surgeons of England·2007

Same author

Use of the CRABEL Score for improving surgical case-note quality.

Annals of the Royal College of Surgeons of England·2005

Same author

Ischaemic foot: an unusual cause.

Postgraduate medical journal·2002

Same author

Accuracy of carotid duplex is laboratory specific and must be determined by internal audit.

European journal of vascular and endovascular surgery : the official journal of the European Society for Vascular Surgery·1998

Same author

Reconstruction of the SMA after excision of an anomalous splenic artery aneurysm.

European journal of vascular and endovascular surgery : the official journal of the European Society for Vascular Surgery·1998

Same author

The management of pyloric stenosis in a district hospital.

Journal of the Royal College of Surgeons of Edinburgh·1997

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Severe acute pancreatitis (AP) causes immune compromise, with reduced T-lymphocytes during acute phases. This cellular immune dysfunction is linked to endotoxin susceptibility and can be improved with interleukin-2 (IL-2) therapy.

Area of Science:

Immunology
Critical Care Medicine
Gastroenterology

Background:

Severe acute pancreatitis (AP) shares clinical similarities with sepsis, post-operative infections, and trauma.
The immunological compromise in severe AP warrants detailed investigation.

Purpose of the Study:

To elucidate the nature of immunological compromise in severe AP.
To investigate cellular immune abnormalities and their association with endotoxin susceptibility.
To evaluate the efficacy of immunomodulatory therapies in AP.

Main Methods:

Assessed lymphocyte surface marker antigen expression (CD3, CD4, CD8) in human AP patients.
Utilized a murine model of AP to study cellular immune responses and endotoxin challenge.
Administered immunomodulatory therapies, including exogenous interleukin-2 (IL-2) and induced endotoxin tolerance.

Related Experiment Videos

Main Results:

Severe AP showed significant reductions in T-lymphocyte subsets (CD3, CD4, CD8) during acute phases, which were reversible in convalescence.
Murine models demonstrated decreased interleukin-2 (IL-2) production and increased susceptibility to endotoxin.
Immunomodulatory therapies (IL-2, endotoxin tolerance) increased IL-2 production and significantly reduced mortality after endotoxin exposure.

Conclusions:

Cellular immune dysfunction is a key feature of severe AP in both humans and animal models.
This immune dysfunction is linked to endotoxin exposure and increased susceptibility to its adverse effects.
Exogenous IL-2 therapy and endotoxin tolerance show potential for partially reversing immune dysfunction and improving outcomes in AP.